Dextrose solution used for prolotherapy decreases cell viability and increases gene expressions of angiogenic and apopitotic factors

Autor:	Ertan Altaylı, Zehra Dilşad Çoban, Özlem Karasimav, Şefik Güran, Naci Karaagac, Sümeyye Demirhan, Aydan Örsçelik, Yavuz Yildiz
Rok vydání:	2018
Předmět:	030222 orthopedics Dextrose solution business.industry Prolotherapy medicine.medical_treatment General Medicine Pharmacology 03 medical and health sciences 0302 clinical medicine Medicine Viability assay business Gene 030217 neurology & neurosurgery
Zdroj:	GULHANE MEDICAL JOURNAL. 60:42
ISSN:	2146-8052
DOI:	10.26657/gulhane.00016
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::1abf7d9faf5d454d61b53325b3dd520e https://doi.org/10.26657/gulhane.00016 Zobrazit plný text záznamu Plný text ve formátu PDF